AHIMA17: Healthcare organizations recognize need for information governance

Implementation of information governance practices—or at least a need to implement them in the future—is growing, according to a survey released at the American Health Information Management Association (AHIMA) conference in Los Angeles.

Out of the more 1,500 healthcare professionals surveyed:

  • 53 percent said they have information governance practices “in place” or recognize the need to adopt such practices.
  • 14 percent have started an information governance program throughout their organization.
  • 18 percent have related projects underway.
  • 85 percent said they’re familiar with the principles of information governance.

“Our goal with this survey was to collect details on successes, obstacles and opportunities from healthcare professionals who are utilizing (information governance) programs,” said AHIMA interim CEO Pamela Lane, MS. “Our analysis shows that we have made progress in this arena and will continue to offer services for even more growth.”

Lane added that adopting governance gives providers “a competitive edge,” offering benefits like “risk reduction, cost avoidance and streamlined operations.”

For organizations without such a program, AHIMA has recommended starting with a data governance program, moving onto gathering support from the C-suite for a “more robust” information governance initiative. It also recommended developing an organization-wide strategic plan with a clear goal set for a return on their investment.

“It is important for organizations to remember information governance is not a project; it is an ongoing program and a continuous, repeated practice,” Lane said.

""
John Gregory, Senior Writer

John joined TriMed in 2016, focusing on healthcare policy and regulation. After graduating from Columbia College Chicago, he worked at FM News Chicago and Rivet News Radio, and worked on the state government and politics beat for the Illinois Radio Network. Outside of work, you may find him adding to his never-ending graphic novel collection.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.